Jan 23 (Reuters) - Cynata Therapeutics Ltd:
* ENTERED INTO A MOU WITH CELULARITY, INC., FOR COMMERCIAL EVALUATION OF CYNATA‘S CYMERUSTM PRODUCTION TECHNOLOGY​ Source text for Eikon: Further company coverage:
 